Learn and Connect with C5’s Life Sciences IP Portfolio Advisory Board:
C5’s Global Life Sciences IP Advisory board was created as a part of C5’s ongoing effort to provide industry leading content and a world renowned speaker faculty. The board is composed of a selection of advisers from around the globe, including leading pharmaceutical and biotech companies. This ‘inner circle’ counsels C5 on the impact of litigation trends and emerging topics.

Dominic Adair

Bristows LLP (U.K)

Monika Dorda

SVP & General Counsel Global Pharmaceuticals

Dr. Sabrina Duschner

VP Patent Litigation Strategy
Fresenius Kabi Deutschland GmbH

Bert Oosting

Hogan Lovells

Guido Pontremoli, Ph.D.

Global IP Head
Corp. Intellectual Property-Patents
Chiesi Farmaceutici S.p.A.

Laura Reynolds

Associate General Counsel
European IP and Regulatory Litigation
Teva Pharmaceuticals

Shohta Ueno, PhD

Director, Dispute Resolution
Regeneron UK Ltd